Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

High Resolution Nerve Ultrasound in the Diagnosis of Pure Neuritic Leprosy

Roy U, Panwar A, Cartwright MS, et al. Wiley. Journal of Clinical Ultrasound. 2025;
Download PDF
Publication

Accuracy of the newly manufactured multiplex XGEN MASTER LEPRAE molecular kit and the point-of-care Bioclin FAST ML FLOW test for case definition and early diagnosis of leprosy among household contacts

Brandão JG, de Macedo AC, Sousa GJB, et al. Elsevier BV. Diagnostic Microbiology and Infectious Disease. 2025; 113 (2) : 116929.
Download PDF
Publication

Editorial: Advances in the molecular epidemiology and diagnostics of leprosy and other mycobacterial diseases

Gupta Y, Avanzi C, Vera-Cabrera L, et al. Frontiers Media SA. Frontiers in Tropical Diseases. 2025;
Download PDF
Publication

Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study

Rivoire BL, Groathouse NA, TerLouw S, et al. Public Library of Science (PLoS). PLoS Neglected Tropical Diseases. 2014; 8 (5) : 13.
Download PDF
Publication

The role of high-resolution ultrasonography (HRUS) in detecting peripheral neuropathy in leprosy patients and household contacts: a systematic review

Tjiaman MP, Zaidan MZ, Ausath ZF, et al. Lepra. Leprosy Review. 2025; 96 (1) : 13.
Download PDF
Publication

A descriptive study of non-neuropathic ulcers in leprosy: a retrospective study in a tertiary hospital in India

Bains A, Bhatia D, Mandiya S, et al. Lepra. Leprosy Review. 2025; 96 (2) : 1-12.
Download PDF
Publication

Borderline lepromatous leprosy with lymph node infiltration: Dermatology helps to clarify challenging diagnoses

Reis VHMD, Miola AC, Ferreira CAZ, et al. Elsevier BV. Anais Brasileiros de Dermatologia. 2025;
Download PDF
Publication

Diagnostic limitations in leprosy elimination: A descriptive cross-sectional study from a tertiary care teaching hospital of Kolkata, India

Mallick T, Choudhury K, Mullick S, et al. IP Innovative Publication Pvt Ltd. IP International Journal of Medical Microbiology and Tropical Diseases. 2025; 11 (1) : 8.
Download PDF
Publication

Challenges associated with dapsone for leprosy treatment in Indonesia - urgent need for access to alternative antimicrobial drugs

Krismawati H, Harianja M, Oktavian A, et al. Elsevier BV. The Lancet Regional Health - Southeast Asia. 2025;
Download PDF
Publication

A Multicenter evaluation of leprosy rapid test Fast ML Flow Hanseníase in Brazil

Saavedra DP, Nobre ML, Guimarães RA, et al. Springer Science and Business Media LLC. European Journal of Clinical Microbiology & Infectious Diseases. 2025;

Pagination

  • Page 1
  • Next page ››
Subscribe to Diagnostic tests

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD